Associate Prof. of Bioengineering, University of Pisa, Head of In-Vitro Models Group and NanoBioscopy Lab at the National Council of Research Institute of Clinical Physiology (CNR-IFC). Also involved in capacity building in the field of Biomedical Engineering, in association with UNECA and FABLAB Pisa .Author of over 100 peer-reviewed publications and of several patents on microfabrication and on bioreactors, co-founder of 2 high-tech companies.
Associate Professor of Integrative Biology and Neuroscience.
Director, UC Berkeley Field Station for the Study of Behavior, Ecology and Reproduction. Editorial Board of Domestic Animal Endocrinology, Frontiers in Systems and Integrative Pharmacology, Frontiers in Endocrinology
A.W. and Mary Margaret Clausen Distinguished Professor; Director, Hormone Research Institute; and Executive Vice Chancellor and Provost. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences. Dr. Bluestone has spent over 30 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.
Prof. George P Chrousos is internationally recognized for his research on the glucocorticoid signaling system of the cell, on the diseases of the hypothalamic-pituitary-adrenal axis, and on the physiological and molecular mechanisms of stress. He is one of the 250 most cited scientists internationally (ISI highly cited) included not only in the list of Clinical Medicine, but also in that of Biology and Biochemistry, and the highest cited clinical endocrinologist and pediatrician in the world.
Graduated in Medicine and Surgery at the University of Catania, Italy, specialist in Endocrinology and in Internal Medicine, PhD in Endocrinological and Metabolic Sciences.
Professor of Clinical Pathology, University "Magna Græcia" of Catanzaro, Italy.
Director of the Center for Human Nutrition. Member of the American Society for Clinical Investigation, the American Association of Physicians, and the National Academies of Sciences (Institute of Medicine).
Head of the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Duisburg-Essen. Medical Director of LVR-Klinikum Essen, University of Duisburg-Essen. Former President of the German Society of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy.
Prof. Akio Inui is the chairman of the department of Psychosomatic Medicine, Kagoshima University Graduate School, Kagoshima Japan. He completed his M.D. and Ph.D. degrees at Kobe University. He is recognized for his studies in elucidating the role of gut-brain peptides such as ghrelin, and his efforts are now focused on the translational research for better understanding and management of human behavioral disorders, including obesity, cancer cachexia, and eating disorders.
University Professor, MD; Professor h.c. of Ufa Eye Research Institute; Adjunct Professor of Clinical Ophthalmology, New York Presbyterian Hospital, Cornell University, USA; Professor of Ophthalmology, Dept. of Ophthalmology Univ. of Mannheim, Heidelberg, Germany. Former Chairman of Department of Ophthalmology University of Tuebingen, Germany. Author of 3 books on Retinal Detachment Surgery.
1997: PhD Cancer Research Centre of the Russian Academy of Medical Sciences, Moscow.
1997-2001: Postdoc at the University of Regensburg
2001-2007: Junior group leader/PI and lecturer, University of Heidelberg.
2007- 2010:Senior group leader/PI and senior lecturer, University of Heidelberg
2010-2013: Professor, head of the Lab for Cellular and Molecular Biology of Innate Immunity;
2013-permanent: Professor, head of Department for Innate Immunity and Tolerance, University of Heidelberg.
Associate Professor at the Academic Medical Center, University of Amsterdam and Visiting Professor at Université Paris Diderot-Paris 7. Our group is working on unravelling the mechanistic link between diet composition and the development of obesity and diabetes as a first step towards better understanding the pathogenesis of Type 2 Diabetes Mellitus, focussing on the role of the brain.